Earnings Per Share, Basic of ELITE PHARMACEUTICALS INC /NV/ from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Earnings Per Share, Basic for the quarter ending 31 Dec 2025 was 0.02.
  • ELITE PHARMACEUTICALS INC /NV/ Earnings Per Share, Basic for the twelve months ending 31 Dec 2025 was 0.04.
  • ELITE PHARMACEUTICALS INC /NV/ annual Earnings Per Share, Basic for 2024 was 0, a 100% decline from 2023.
  • ELITE PHARMACEUTICALS INC /NV/ annual Earnings Per Share, Basic for 2023 was 0.02.
  • ELITE PHARMACEUTICALS INC /NV/ annual Earnings Per Share, Basic for 2022 was 0, a 100% decline from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 0.04 0.02 +0.03 01 Oct 2025 31 Dec 2025 10-Q 17 Feb 2026 2026 Q3
Q3 2025 0.01 0.01 +0.02 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 -0.01 -0.01 -0.01 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 0 0.02 +0.01 +100% 01 Jan 2025 31 Mar 2025 10-K 30 Jun 2025 2025 FY
Q4 2024 -0.01 -0.01 -0.01 01 Oct 2024 31 Dec 2024 10-Q 17 Feb 2026 2026 Q3
Q3 2024 0 -0.01 -0.02 -200% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q2
Q2 2024 0.02 0 0 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q1 2024 0.02 0.01 +0.01 01 Jan 2024 31 Mar 2024 10-K 30 Jun 2025 2025 FY
Q4 2023 0.01 0 0 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2025 Q3
Q3 2023 0.01 0.01 +0.01 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q2
Q2 2023 0 0 0 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2025 Q1
Q1 2023 0 0 -0.01 -100% 01 Jan 2023 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q4 2022 0.01 0 0 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q3
Q3 2022 0.01 0 0 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q2
Q2 2022 0.01 0 0 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2024 Q1
Q1 2022 0.01 0.01 0 0% 01 Jan 2022 31 Mar 2022 10-K 29 Jun 2023 2023 FY
Q4 2021 0.01 0 0 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q3
Q3 2021 0.01 0 0 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q2
Q2 2021 0.01 0 0 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2023 Q1
Q1 2021 0.01 0.01 +0.01 01 Jan 2021 31 Mar 2021 10-K 29 Jun 2022 2022 FY
Q4 2020 0 0 0 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022 2022 Q3
Q3 2020 0 0 0 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2022 Q2
Q2 2020 0 0 0 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2022 Q1
Q1 2020 0 0 +0.01 01 Jan 2020 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q4 2019 -0.01 0 0 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021 2021 Q3
Q3 2019 -0.01 0 0 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2021 Q2
Q2 2019 -0.01 0 0 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020 2021 Q1
Q1 2019 -0.01 -0.01 -0.01 01 Jan 2019 31 Mar 2019 10-K 29 Jun 2020 2020 FY
Q4 2018 0 0 0 01 Oct 2018 31 Dec 2018 10-Q 10 Feb 2020 2020 Q3
Q3 2018 0 0 0 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2020 Q2
Q2 2018 0 0 0 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2020 Q1
Q1 2018 0 0 -0.03 -100% 01 Jan 2018 31 Mar 2018 10-K 14 Jun 2018 2018 FY
Q4 2017 0.03 0 0 01 Oct 2017 31 Dec 2017 10-Q 11 Feb 2019 2019 Q3
Q3 2017 0.03 0 -0.03 -100% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2019 Q2
Q2 2017 0.06 0 0 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2019 Q1
Q1 2017 0.06 0.03 0 0% 01 Jan 2017 31 Mar 2017 10-K 14 Jun 2018 2018 FY
Q4 2016 0.06 0 +0.05 01 Oct 2016 31 Dec 2016 10-K 14 Jun 2018 2018 FY
Q3 2016 0.01 0.03 +0.04 01 Jul 2016 30 Sep 2016 10-K 14 Jun 2018 2018 FY
Q2 2016 -0.03 0 -0.02 -100% 01 Apr 2016 30 Jun 2016 10-K 14 Jun 2018 2018 FY
Q1 2016 -0.01 0.03 +0.04 01 Jan 2016 31 Mar 2016 10-K 14 Jun 2018 2018 FY
Q4 2015 -0.05 -0.05 -0.08 -267% 01 Oct 2015 31 Dec 2015 10-K 14 Jun 2018 2018 FY
Q3 2015 0.03 -0.01 -0.05 -125% 01 Jul 2015 30 Sep 2015 10-K 14 Jun 2018 2018 FY
Q2 2015 0.08 0.02 +0.03 01 Apr 2015 30 Jun 2015 10-K 14 Jun 2018 2018 FY
Q1 2015 0.05 -0.01 +0.15 +94% 01 Jan 2015 31 Mar 2015 10-K 14 Jun 2017 2017 FY
Q4 2014 -0.1 0.03 +0.03 01 Oct 2014 31 Dec 2014 10-K 14 Jun 2017 2017 FY
Q3 2014 -0.13 0.04 +0.06 01 Jul 2014 30 Sep 2014 10-K 14 Jun 2017 2017 FY
Q2 2014 -0.19 -0.01 -0.01 01 Apr 2014 30 Jun 2014 10-K 14 Jun 2017 2017 FY
Q1 2014 -0.18 -0.16 -0.16 01 Jan 2014 31 Mar 2014 10-K 15 Jun 2016 2016 FY
Q4 2013 -0.02 0 -0.03 -100% 01 Oct 2013 31 Dec 2013 10-K 15 Jun 2016 2016 FY
Q3 2013 0.01 -0.02 -0.02 01 Jul 2013 30 Sep 2013 10-K 15 Jun 2016 2016 FY
Q2 2013 0.03 0 +0.03 01 Apr 2013 30 Jun 2013 10-K 15 Jun 2016 2016 FY
Q1 2013 0 0 +0.02 01 Jan 2013 31 Mar 2013 10-K 30 Jun 2014 2014 FY
Q4 2012 -0.02 0.03 0 0% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014 2013 Q3
Q3 2012 -0.02 0 -0.06 -100% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013 2013 Q2
Q2 2012 0.04 -0.03 +0.1 +77% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013 2013 Q1
Q1 2012 -0.06 -0.02 01 Jan 2012 31 Mar 2012 10-K 21 Jun 2013 2012 FY
Q4 2011 0.03 -0.03 -50% 01 Oct 2011 31 Dec 2011 10-Q 14 Feb 2013 2012 Q3
Q3 2011 0.06 +0.04 +200% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2012 Q2
Q2 2011 -0.13 -0.08 -160% 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012 2012 Q1
Q4 2010 0.06 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012 2011 Q3
Q3 2010 0.02 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011 2011 Q2
Q2 2010 -0.05 01 Apr 2010 30 Jun 2010 10-Q/A 19 Aug 2011 2011 Q1

ELITE PHARMACEUTICALS INC /NV/ Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 0 -0.02 -100% 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025 2025 FY
2023 0.02 +0.02 01 Apr 2023 31 Mar 2024 10-K 30 Jun 2025 2025 FY
2022 0 -0.01 -100% 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024 2024 FY
2021 0.01 0 0% 01 Apr 2021 31 Mar 2022 10-K 29 Jun 2023 2023 FY
2020 0.01 +0.01 01 Apr 2020 31 Mar 2021 10-K 29 Jun 2022 2022 FY
2019 0 +0.01 01 Apr 2019 31 Mar 2020 10-K 14 Jun 2021 2021 FY
2018 -0.01 -0.01 01 Apr 2018 31 Mar 2019 10-K 29 Jun 2020 2020 FY
2017 0 -0.03 -100% 01 Apr 2017 31 Mar 2018 10-K 21 Jun 2019 2019 FY
2016 0.03 +0.04 01 Apr 2016 31 Mar 2017 10-K 14 Jun 2018 2018 FY
2015 -0.01 -0.06 -120% 01 Apr 2015 31 Mar 2016 10-K 14 Jun 2018 2018 FY
2014 0.05 +0.26 01 Apr 2014 31 Mar 2015 10-K 14 Jun 2017 2017 FY
2013 -0.21 -0.21 01 Apr 2013 31 Mar 2014 10-K 15 Jun 2016 2016 FY
2012 0 +0.06 01 Apr 2012 31 Mar 2013 10-K 30 Jun 2014 2014 FY
2011 -0.06 01 Apr 2011 31 Mar 2012 10-K 21 Jun 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.